Abbott Laboratories Stock Forecast for 2023 - 2025 - 2030

Updated on 05/28/2024

Stock Rating
9
Price Target
$125.00
Consensus
Outperform
Upside
22.61%
Analysts
7
Stock Rating
9
Upside
22.61%
Analysts
7
Price Target
$125.00

Abbott Laboratories Stock Forecast and Price Target

Abbott Laboratories's stock price reaches the average target of $125.00 by 2025 as expected recently by seven notable experts, there would be a potential upside of approximately 22.61% from the last closing price in May, 2024. This possible increase is based on a high estimate of $143.00 and a low estimate of $104.00. If you are interested in ABT stock, it is important to also consider its competitors.

$125.00

22.61% Upside

Outperform
Outperform

Abbott Laboratories Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Abbott Laboratories's Price has decreased from $82.27 to $0.00 – a 100.00% drop. For next year, analysts predict Fair Value of $124.65, which would mean an increase of 100.00%. Over the next seven years, experts predict that Abbott Laboratories's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$124.65
2025 Fair Value Forecast
$137.49
2026 Fair Value Forecast
$149.89
2027 Fair Value Forecast
$153.72
2028 Fair Value Forecast
$159.81
2029 Fair Value Forecast
$170.85
2030 Fair Value Forecast
$187.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$807.86 Buy/Sell $636.99 8.62%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£120.28 Buy/Sell £165.99 40.24%
DHR Stock Forecast Danaher Outperform 10
$258.71 Buy/Sell $260.33 5.30%
AMAT Stock Forecast Applied Materials Inc Outperform 8
$221.32 Buy/Sell $168.54 8.44%
AMGN Stock Forecast Amgen Outperform 4
$300.19 Buy/Sell $303.65 7.36%

Abbott Laboratories Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Revenue has grown by 15.90%, rising from $34.61B to $40.11B. For next year, analysts predict Revenue of $44.20B, which would mean an increase of 10.20%. Over the next seven years, experts predict that Abbott Laboratories's Revenue will grow at a rate of 27.68%.

2024 Rev Forecast
$44.20B
2025 Rev Forecast
$46.58B
2026 Rev Forecast
$49.65B
2027 Rev Forecast
$52.10B
2028 Rev Forecast
$54.81B
2029 Rev Forecast
$51.92B
2030 Rev Forecast
$51.21B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BSX Stock Forecast Boston Scientific Buy 11
$75.17 Buy/Sell $70.14 9.09%
CSL Stock Forecast CSL Outperform 12
$281.96 Buy/Sell $205.51 -27.13%
CL Stock Forecast Colgate-Palmolive Co Outperform 18
$91.94 Buy/Sell $88.97 7.14%

Abbott Laboratories Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's Dividend per Share has grown, rising from $1.53 to $2.08 – a growth of 35.95%. In the next year, analysts believe that Dividend per Share will reach $2.11 – an increase of 1.44%. For the next seven years, the forecast is for Dividend per Share to grow by 24.33%.

2024 DPS Forecast
$2.11
2025 DPS Forecast
$2.53
2026 DPS Forecast
$2.78
2027 DPS Forecast
$2.45
2028 DPS Forecast
$2.45
2029 DPS Forecast
$2.49
2030 DPS Forecast
$2.59
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$226.80 Buy/Sell $284.47 23.46%
MMM Stock Forecast 3M Hold 10
$98.68 Buy/Sell $109.39 4.88%
EW Stock Forecast Edwards Lifesciences Corp Outperform 11
$87.04 Buy/Sell $91.18 14.89%

Abbott Laboratories Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$9.04B
2025 FCF Forecast
$9.48B
2026 FCF Forecast
$9.58B
2027 FCF Forecast
$13.70B
2028 FCF Forecast
$9.30B
2029 FCF Forecast
$9.80B
2030 FCF Forecast
$10.20B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
DXCM Stock Forecast DexCom Inc Buy 12
$127.38 Buy/Sell $125.98 19.45%
A Stock Forecast Agilent Technologies Outperform 10
$148.21 Buy/Sell $138.82 1.88%
BN Stock Forecast Danone Outperform 11
58.78€ Buy/Sell 55.47€ 8.88%

Abbott Laboratories EBITDA Forecast for 2023 - 2025 - 2030

Abbott Laboratories's EBITDA has seen impressive growth In the last three years, rising from $8.99B to $10.46B – a growth of 16.36%. In the next year, analysts believe that EBITDA will reach $13.15B – an increase of 25.66%. For the next seven years, the forecast is for EBITDA to grow by 28.90%.

2024 EBITDA Forecast
$13.15B
2025 EBITDA Forecast
$12.29B
2026 EBITDA Forecast
$13.49B
2027 EBITDA Forecast
$12.71B
2028 EBITDA Forecast
$13.99B
2029 EBITDA Forecast
$13.44B
2030 EBITDA Forecast
$13.49B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BAYN Stock Forecast Bayer Hold 5
27.80€ Buy/Sell 45.15€ 7.91%
CHD Stock Forecast Church & Dwight Co Inc Hold 11
$104.16 Buy/Sell $96.90 3.69%
CAH Stock Forecast Cardinal Health Inc Hold 13
$94.75 Buy/Sell $108.07 20.84%

Abbott Laboratories EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Abbott Laboratories's EBIT has grown by 27.45%, rising from $5.67B to $7.22B. For the next year, analysts predict that EBIT will reach $11.31B – an increase of 56.67%. Over the next seven years, experts believe that Abbott Laboratories's EBIT will grow at a rate of 137.85%.

2024 EBIT Forecast
$11.31B
2025 EBIT Forecast
$12.07B
2026 EBIT Forecast
$13.81B
2027 EBIT Forecast
$14.30B
2028 EBIT Forecast
$13.95B
2029 EBIT Forecast
$11.74B
2030 EBIT Forecast
$17.17B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
7751 Stock Forecast Canon Hold 18
¥4.28k Buy/Sell ¥3.74k -11.24%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.56k Buy/Sell ¥2.64k 24.80%
BAX Stock Forecast Baxter International Inc Hold 17
$33.85 Buy/Sell $44.86 29.99%

Abbott Laboratories EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Abbott Laboratories's EPS has decreased from $3.65 to $0.00 – a 100.00% drop. For next year, analysts predict EPS of $5.53, which would mean an increase of 100.00%. Over the next seven years, experts predict that Abbott Laboratories's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$5.53
2025 EPS Forecast
$6.10
2026 EPS Forecast
$6.65
2027 EPS Forecast
$6.82
2028 EPS Forecast
$7.09
2029 EPS Forecast
$7.58
2030 EPS Forecast
$8.34
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABMD Stock Forecast Abiomed - 16
$377.79 Buy/Sell $380.00 -88.33%
CIPLA Stock Forecast Cipla Outperform 18
Rp1.48k Buy/Sell Rp1.43k 4.16%
BIM Stock Forecast bioMérieux Outperform 18
94.15€ Buy/Sell 105.55€ 22.15%